期刊文献+

超声评分系统、螺旋CT及术前血清检查鉴别诊断青春期卵巢肿瘤的价值 被引量:9

Value of Ultrasound Scoring System,Spiral CT,and Preoperative Serum Examination in the Differential Diagnosis of Ovarian Tumors in Adolescent
下载PDF
导出
摘要 目的研究超声评分系统、螺旋CT及血清学指标在鉴别青春期卵巢肿瘤中的价值。方法将医院2016年1月至2018年1月间,96例经手术病理确诊为青春期卵巢肿瘤患者纳为研究对象,以手术病理结果为“金标准”,研究超声评分系统、螺旋CT及血清学指标在诊断青春期良恶性卵巢肿瘤中的价值。结果96例患者全部行手术治疗,术中冰冻检查提示良性61例,恶性35例,青春期卵巢恶性肿瘤以生殖细胞肿瘤为主的有45.71%(16/35);共91例患者术前行彩色多普勒超声检查,Alaczar评分系统在鉴别青春期卵巢肿瘤良恶性中的灵敏度、特异度及准确度分别为91.23%、91.18%和91.21%;共20例患者术前行螺旋CT检查,螺旋CT在鉴别青春期卵巢肿瘤中的灵敏度、特异度及准确度分别为75.00%、93.75%和90.00%;所有患者术前均行血清学检查,检查结果提示血清癌胚抗原125(CA125)水平异常者66例(44~569.45U/mL),术后病理检查提示良性病变51例,恶性病变15例;血清糖链抗原199(CA199)水平异常者26例(46~151U/mL),其中良性病变7例,恶性病变19例;血清甲胎蛋白(AFP)水平异常者16例(215.15~3751.21ng/mL),病理检查提示恶性病变者9例,良性病变者7例。结论青春期卵巢肿瘤发病隐匿,临床表现缺乏特异性,需医者仔细检查,结合各种信息加以判断,而超声评分系统、螺旋CT及血清肿瘤标志物在辅助鉴别青春期卵巢肿瘤良恶性中均具有一定效能。 Objective To investigate the value of ultrasound scoring system,spiral CT and preoperative serum examination in differential diagnosis of ovarian tumors in adolescent.Methods 96 adolescents with pathologically confirmed ovarian tumors in our hospital from January 2016 to January 2018 were enrolled.Taking the surgical pathological results as the"gold standard",the diagnostic value of ultrasound scoring system,spiral CT,and serological indexes in the diagnosis of benign and malignant ovarian tumors in adolescence was studied.Results All 96 patients were treated by operation.The intraoperative frozen-section examination showed that 61 cases were benign and 35 cases were malignant.The majority of ovarian malignant tumors in adolescence were germ cell tumors(45.71%,16/35).A total of 91 patients underwent color doppler ultrasonography before operation.The sensitivity,specificity and accuracy of the Alaczar scoring system in differentiating benign and malignant ovarian tumors in adolescence were 91.23%,91.18%,and 91.21%,respectively.A total of 20 patients underwent preoperative spiral CT examination.The sensitivity,specificity and accuracy of spiral CT in differentiating benign and malignant ovarian tumors were 75.00%,93.75%,and 90.00%,respectively.All patients underwent serological examination before surgery,and the results indicated that 66 patients with abnormal serum oncoembryonic antigen 125 levels(CA125:44~569.45U/mL),including 51 patients with benign lesions and 15 patients with malignant lesions.There were 26 cases with abnormal serum glucose chain antigen level(CA199:46~151U/mL),including 7 cases of benign lesions and 19 cases of malignant lesions.There were 16 cases with abnormal serum alpha-fetoprotein(AFP:215.15~3751.21ng/mL)levels,including 9 cases with malignant lesions and 7 cases with benign lesions.Conclusion The onset of adolescent ovarian tumors is occult,and the clinical manifestations are lack of specificity.Careful examination combined with various information is used in clinical judgment,and the ultrasound scoring system,spiral CT,and serum tumor markers have certain efficacy in helping to differentiate the benign and malignant ovarian tumors in adolescence.
作者 周小森 洪克华 赵小春 周钰 肖春蕾 ZHOU Xiao-sen;HONG Ke-hua;ZHAO Xiao-chun;ZHOU Yu;XIAO Chun-lei(Department of Radiology,Tangshan Maternal and Child Health Hospital,Tangshan 063000,Hebei Province,China;Department of Ultrasound Medicine,Tangshan Maternal and Child Health Hospital,Tangshan 063000,Hebei Province,China)
出处 《中国CT和MRI杂志》 2022年第3期129-131,170,共4页 Chinese Journal of CT and MRI
基金 河北省2020年度医学科学研究课题(20201477)。
关键词 青春期卵巢肿瘤 超声评分系统 螺旋CT 血清学指标 Adolescent Ovarian Tumors Ultrasound Scoring System Spiral CT Serological Indicators
  • 相关文献

参考文献10

二级参考文献82

  • 1李巍,崔恒,冯捷,李艺.卵巢癌诊断的研究进展[J].中华妇产科杂志,2005,40(7):496-498. 被引量:74
  • 2蒋玉萍,吴小华,邢邯英,杜行严.趋化因子CXCL12及其受体CXCR4对卵巢上皮性癌细胞增殖、迁移和侵袭能力的影响[J].中华妇产科杂志,2007,42(6):403-407. 被引量:17
  • 3全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 4Torte LA,Bray F,Siegel RL,et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2) : 87-108.
  • 5Chou JL,Su HY,Chen LY,et al. Promoter hypermethylation of FBX032,a novel TGF-p/SMAIM target gene and tumor suppressor,is associated with poor prognosis in human ovarian cancer[J]. Lab Invest, 2010,90(3) :414-425.
  • 6Curado MPEB,Shin HR,Storm H,et al. Cancer Incidence in Five Continents, Vol. Ⅸ [M].Lyon : IARC Scientific Publications, 2008.
  • 7Bray F,Parkin DM. Evaluation of data quality in the cancer registry :principles and methods. Part Ⅰ :comparability,validity and timeliness [J]. Eur J Cancer,2009,45(5): 747-755.
  • 8Parkin DM,Chen VW,Ferlay J,et al. Comparability and quality control in cancer registration. IARC technical report No. 19[M]. Lyon : IARC, 1994.
  • 9Felay J,Burkhard C,Whelan S,et al. Check and Conversion Programs for Cancer Registries. IARC Technical Report No.42[M].Lyon : IARC, 2005.
  • 10Felay J. The IARCcrgTools program[EB/OL], http ://www.iacr.com.fr/iarccrgtools.htm. IACR. Lyon. 2006.

共引文献299

同被引文献91

引证文献9

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部